Genomic Health Reports 19 Percent Revenue Growth for Q4, FY 2010

The firm's revenues jumped on increased OncoType Dx sales, and it posted a profit for both the quarter and year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories